Følg
Finn Sellebjerg
Finn Sellebjerg
Professor i Neurologi, Rigshospitalet, Københavns Universitet
Verificeret mail på dadlnet.dk
Titel
Citeret af
Citeret af
År
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Nature 476 (7359), 214-219, 2011
29752011
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
International IBD Genetics Consortium (IIBDGC), C Agliardi, L Alfredsson, ...
Nature genetics 45 (11), 1353-1360, 2013
13432013
Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients
TL Sørensen, M Tani, J Jensen, V Pierce, C Lucchinetti, VA Folcik, S Qin, ...
The Journal of clinical investigation 103 (6), 807-815, 1999
12291999
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
International Multiple Sclerosis Genetics Consortium*†, ANZgene, ...
Science 365 (6460), eaav7188, 2019
9072019
Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement
MS Freedman, EJ Thompson, F Deisenhammer, G Giovannoni, ...
Archives of neurology 62 (6), 865-870, 2005
7552005
Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis
C Bridel, WN Van Wieringen, H Zetterberg, BM Tijms, CE Teunissen, ...
JAMA neurology 76 (9), 1035-1048, 2019
5652019
Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force
F Deisenhammer, A Bartos, R Egg, NE Gilhus, G Giovannoni, S Rauer, ...
European journal of neurology 13 (9), 913-922, 2006
4052006
Clinical relevance of brain volume measures in multiple sclerosis
N De Stefano, L Airas, N Grigoriadis, HP Mattle, J O’Riordan, ...
CNS drugs 28, 147-156, 2014
3782014
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open …
R Kapoor, PR Ho, N Campbell, I Chang, A Deykin, F Forrestal, N Lucas, ...
The Lancet Neurology 17 (5), 405-415, 2018
3362018
Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course
M Khademi, I Kockum, ML Andersson, E Iacobaeus, L Brundin, ...
Multiple Sclerosis Journal 17 (3), 335-343, 2011
3002011
CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis
C Trebst, TL Sørensen, P Kivisäkk, MK Cathcart, J Hesselgesser, R Horuk, ...
The American journal of pathology 159 (5), 1701-1710, 2001
2992001
Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17-and activated B-cells and correlates with progression
JR Christensen, L Börnsen, R Ratzer, F Piehl, M Khademi, T Olsson, ...
PloS one 8 (3), e57820, 2013
2962013
Multiple sclerosis: a study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system
TL Sørensen, C Trebst, P Kivisäkk, KL Klaege, A Majmudar, R Ravid, ...
Journal of neuroimmunology 127 (1-2), 59-68, 2002
2852002
Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS
F Sellebjerg, L Bornsen, M Khademi, M Krakauer, T Olsson, ...
Neurology 73 (23), 2003-2010, 2009
2582009
T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis
CJ Hedegaard, M Krakauer, K Bendtzen, H Lund, F Sellebjerg, ...
Immunology 125 (2), 161-169, 2008
2372008
CCR5 Δ32, matrix metalloproteinase-9 and disease activity in multiple sclerosis
F Sellebjerg, HO Madsen, CV Jensen, J Jensen, P Garred
Journal of Neuroimmunology 102 (1), 98-106, 2000
2082000
EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapses
F Sellebjerg, D Barnes, G Filippini, R Midgard, X Montalban, ...
European journal of neurology 12 (12), 939-946, 2005
2002005
Double-blind, randomized, placebo-controlled study of oral, high-dose methylprednisolone in attacks of MS
F Sellebjerg, JL Frederiksen, PM Nielsen, J Olesen
Neurology 51 (2), 529-534, 1998
1991998
Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice
JCC de Sa, L Airas, E Bartholome, N Grigoriadis, H Mattle, ...
Therapeutic advances in neurological disorders 4 (3), 139-168, 2011
1892011
A meta-analysis of methylprednisolone in recovery from multiple sclerosis exacerbations
DM Miller, B Weinstock-Guttman, F Béthoux, JC Lee, G Beck, V Block, ...
Multiple Sclerosis Journal 6 (4), 267-273, 2000
1832000
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20